Innocan Pharma Corp (INNO.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 13 | 13 | 10 | 10 | 10 |
| Accounts receivable | -127 | -262 | -172 | -138 | 107 |
| Accounts payable and accrued liabilities | 101 | -33 | -254 | 192 | -379 |
| Other Working Capital | -233 | -246 | -302 | -92 | -329 |
| Other Operating Activity | -1,332 | -1,824 | -629 | -1,008 | -1,303 |
| Operating Cash Flow | $-1,578 | $-2,352 | $-1,347 | $-1,036 | $-1,894 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -11 | 0 | N/A | N/A | N/A |
| Other Investing Activity | 0 | -7 | 0 | 0 | 0 |
| Investing Cash Flow | $-11 | $-7 | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -15 | -9 | -10 | -9 | -10 |
| Common Stock Issued | 0 | 2,897 | 0 | 0 | 1,017 |
| Other Financing Activity | 3 | 4,561 | 2,706 | 1,200 | 2,960 |
| Financing Cash Flow | $-12 | $7,449 | $2,696 | $1,191 | $3,967 |
| Exchange Rate Effect | 100 | 92 | -86 | 92 | -14 |
| Beginning Cash Position | 11,048 | 5,866 | 4,644 | 4,397 | 2,338 |
| End Cash Position | 9,547 | 11,048 | 5,866 | 4,644 | 4,397 |
| Net Cash Flow | $-1,601 | $5,090 | $1,308 | $155 | $2,073 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,578 | -2,352 | -1,347 | -1,036 | -1,894 |
| Capital Expenditure | -11 | N/A | N/A | N/A | N/A |
| Free Cash Flow | -1,589 | -2,352 | -1,347 | -1,036 | -1,894 |